tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Corinne Jenkins, 43 are a BUY (54.43%), 26 are a HOLD (32.91%), 10 are a SELL (12.66%).
Analyst Corinne Jenkins, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 59.73% that have a potential upside of 33.63% achieved within 148 days.
Corinne Jenkins’s has documented 160 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RYTM, Rhythm Pharmaceuticals at 05-Dec-2024.
Analyst best performing recommendations are on AMAM (AMBRX BIOPHARMA . AMERICAN DEPOSITARY SHARES).
The best stock recommendation documented was for AMAM (AMBRX BIOPHARMA . AMERICAN DEPOSITARY SHARES) at 9/13/2023. The price target of $10 was fulfilled within 1 day with a profit of $1.16 (10.39%) receiving and performance score of 103.94.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$22
$3.21 (17.08%)
$12
9 days ago
(02-Dec-2024)
3/6 (50%)
$2.57 (13.23%)
344
Sell
$17.5
6 months 11 days ago
(30-May-2024)
1/1 (100%)
$-3.09 (-15.01%)
44
Hold
2 years 5 months 17 days ago
(24-Jun-2022)
9/9 (100%)
$-26.36 (-56.86%)
557
Hold
$10
$-17.85 (-64.09%)
$7
2 years 5 months 17 days ago
(24-Jun-2022)
1/2 (50%)
$0.43 (7.40%)
15
Sell
$8
$-19.85 (-71.27%)
$16
2 years 6 months 3 days ago
(08-Jun-2022)
2/2 (100%)
$0.9 (8.53%)
132
Which stock is Corinne Jenkins is most bullish on?
Which stock is Corinne Jenkins is most reserved on?
What Year was the first public recommendation made by Corinne Jenkins?
